Why Coursera, Inc. (NYSE:COUR) Could Be Worth Watching
Coursera 'Well-Positioned' in GenAI World Due to Global Client Base, Multi-Sided Business Model, RBC Says
RBC Capital Maintains Coursera(COUR.US) With Buy Rating, Maintains Target Price $18
RBC Capital analyst Rishi Jaluria maintains $Coursera(COUR.US)$ with a buy rating, and maintains the target price at $18.According to TipRanks data, the analyst has a success rate of 49.4% and a
Moderna And Coursera Disclosed A Partnership To Launch MRNAs As Medicines, A Three-module Course Designed By Experts At Moderna That Offers A Comprehensive Understanding Of MRNA Medicines
Moderna and Coursera Launch Free Course on MRNA Technology
DeepL, Incluida En La Lista Forbes Cloud 100 Por Segundo Año Consecutivo